ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market
Holding AVBP?
Track your performance easily

ArriVent BioPharma, Inc. (AVBP) Technical Analysis

20 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
6Bearish
ArriVent BioPharma, Inc.’s (AVBP) Moving Averages Convergence Divergence (MACD) indicator is 0.26, suggesting ArriVent BioPharma, Inc. is a Buy.
ArriVent BioPharma, Inc.’s (AVBP) 20-Day exponential moving average is 24.96, while ArriVent BioPharma, Inc.’s (AVBP) share price is $24.2, making it a Sell.
ArriVent BioPharma, Inc.’s (AVBP) 50-Day exponential moving average is 23.46, while ArriVent BioPharma, Inc.’s (AVBP) share price is $24.2, making it a Buy.

ArriVent BioPharma, Inc. (AVBP) Pivot Points

Sep 20, 2024, 09:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.20
23.04
23.49
24.32
24.77
25.61
26.06
Fibonacci
23.04
23.53
23.83
24.32
24.81
25.12
25.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ArriVent BioPharma, Inc. (AVBP) Moving Averages

Sep 20, 2024, 09:35 AM
Period
Simple
Exponential
MA5
23.92Sell
24.24Sell
MA10
25.46Sell
24.86Sell
MA20
25.73Sell
24.96Sell
MA50
23.08Buy
23.46Buy
MA100
20.67Buy
21.87Buy
ArriVent BioPharma, Inc.’s (AVBP) 10-Day exponential moving average is 24.86, while ArriVent BioPharma, Inc.’s (AVBP) share price is $24.2, making it a Sell.
ArriVent BioPharma, Inc.’s (AVBP) 100-Day exponential moving average is 21.87, while ArriVent BioPharma, Inc.’s (AVBP) share price is $24.2, making it a Buy.
ArriVent BioPharma, Inc.’s (AVBP) stock price is $24.2 and ArriVent BioPharma, Inc.’s (AVBP) 50-day simple moving average is 23.08, creating a Buy signal.
ArriVent BioPharma, Inc.’s (AVBP) stock price is $24.2 and ArriVent BioPharma, Inc.’s (AVBP) 100-day simple moving average is 20.67, creating a Buy signal.

ArriVent BioPharma, Inc. (AVBP) Technical Indicators

Sep 20, 2024, 09:35 AM
Name
Value
Implied Action
RSI (14)
43.75
Neutral
STOCH (9,6)
19.83
Buy
STOCHRSI (14)
19.83
Buy
MACD (12,26)
0.26
Buy
ADX (14)
28.89
Neutral
Williams %R
-85.16
Buy
CCI (14)
-93.69
Neutral
ATR (14)
1.67
-
Ultimate Oscillator
33.05
Neutral
ROC
-13.30
Sell
ArriVent BioPharma, Inc.’s (AVBP) Relative Strength Index (RSI) is 43.75, creating a Neutral signal.
ArriVent BioPharma, Inc.’s (AVBP) Trend Strength Indicator (ADX) is 28.89, creating a Neutral signal.
ArriVent BioPharma, Inc.’s (AVBP) Commodity Channel Index (CCI) is -93.69, creating a Neutral signal.
ArriVent BioPharma, Inc.’s (AVBP) Price Rate of Change (ROC) is -13.30, creating a Sell signal.

FAQ

Is AVBP a Buy, Hold, or Sell?
Based on AVBP’s technical indicators, AVBP is a Hold.
    What is AVBP’s RSI (14)?
    AVBP’s RSI (14) is 43.75, which suggests AVBP is a Neutral.
      What is AVBP’s MACD?
      AVBP’s MACD is 0.26, which suggests AVBP is a Buy.
        What is AVBP’s 5-day moving average?
        AVBP’s 5-day moving average is 23.92, which suggests AVBP is a Sell.
          What is AVBP’s 20-day moving average?
          AVBP 20-day moving average is 25.73, which suggests AVBP is a Sell.
            What is AVBP’s 50-day moving average?
            AVBP’s 50-day moving average is 23.08, which suggests AVBP is a Buy.
              What is AVBP’s 200-day moving average?
              Currently, no data Available
              What is AVBP’s Williams % R (14)?
              AVBP’s Williams % R (14) is -85.16, which suggests AVBP is a Buy.
                What is AVBP’s CCI (14)?
                AVBP’s CCI (14) is -93.69, which suggests AVBP is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis